Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
13,253
archived clinical trials in
Arthritis

Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  11/5/2015
mi
from
Lee's Summit, MO
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Kansas City Internal Medicine
mi
from
Lee's Summit, MO
Click here to add this to my saved trials
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  11/5/2015
mi
from
Lincoln, NE
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Physician Research Collaboration
mi
from
Lincoln, NE
Click here to add this to my saved trials
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  11/5/2015
mi
from
Dover, NJ
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Allergy And Arthritis Associates
mi
from
Dover, NJ
Click here to add this to my saved trials
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  11/5/2015
mi
from
Albuquerque, NM
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Albuquerque Clinical Trials
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  11/5/2015
mi
from
Albuquerque, NM
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Albuquerque Rehabilitation & Rheumatology, PC
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  11/5/2015
mi
from
Albany, NY
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
The Center for Rheumatology, LLP
mi
from
Albany, NY
Click here to add this to my saved trials
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  11/5/2015
mi
from
Olean, NY
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Southern Tier Arthritis and Rheumatism
mi
from
Olean, NY
Click here to add this to my saved trials
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  11/5/2015
mi
from
Syracuse, NY
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Arthritis Health Associates
mi
from
Syracuse, NY
Click here to add this to my saved trials
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  11/5/2015
mi
from
Asheville, NC
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Asheville Rheumatology & Osteoporosis Research Asso P. A.
mi
from
Asheville, NC
Click here to add this to my saved trials
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  11/5/2015
mi
from
Charlotte, NC
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
The Arthritis Clinic & Carolina Bone & Joint
mi
from
Charlotte, NC
Click here to add this to my saved trials
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  11/5/2015
mi
from
Durham, NC
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Rheumatology
mi
from
Durham, NC
Click here to add this to my saved trials
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  11/5/2015
mi
from
Greenville, NC
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Physician's East
mi
from
Greenville, NC
Click here to add this to my saved trials
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  11/5/2015
mi
from
Statesville, NC
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Carolina Pharmaceutical Research
mi
from
Statesville, NC
Click here to add this to my saved trials
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  11/5/2015
mi
from
Wilmington, NC
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Carolina Arthritis Associates
mi
from
Wilmington, NC
Click here to add this to my saved trials
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  11/5/2015
mi
from
Cincinnati, OH
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Cincinnati Rheumatic Disease Study Group
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  11/5/2015
mi
from
Oklahoma City, OK
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Health Research of Oklahoma
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  11/5/2015
mi
from
Tulsa, OK
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Oklahoma Center for Arthritis Therapy & Research, Inc.
mi
from
Tulsa, OK
Click here to add this to my saved trials
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  11/5/2015
mi
from
Tulsa, OK
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Healthcare Research Consultants
mi
from
Tulsa, OK
Click here to add this to my saved trials
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  11/5/2015
mi
from
Eugene, OR
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Pro Research
mi
from
Eugene, OR
Click here to add this to my saved trials
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  11/5/2015
mi
from
Lake Oswego, OR
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Portland Rheumatology Clinic, Llc
mi
from
Lake Oswego, OR
Click here to add this to my saved trials
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  11/5/2015
mi
from
Bethlehem, PA
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
East Penn Rheumatology Associates, P.C.
mi
from
Bethlehem, PA
Click here to add this to my saved trials
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  11/5/2015
mi
from
Providence, RI
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Rheumatology Associates
mi
from
Providence, RI
Click here to add this to my saved trials
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  11/5/2015
mi
from
Charleston, SC
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Low Country Rheumatology
mi
from
Charleston, SC
Click here to add this to my saved trials
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  11/5/2015
mi
from
Columbia, SC
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Columbia Arthritis Center, P.A.
mi
from
Columbia, SC
Click here to add this to my saved trials
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  11/5/2015
mi
from
Myrtle Beach, SC
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Carolina Health Specialists
mi
from
Myrtle Beach, SC
Click here to add this to my saved trials
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  11/5/2015
mi
from
Orangeburg, SC
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Acme Research L.L.C.
mi
from
Orangeburg, SC
Click here to add this to my saved trials
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  11/5/2015
mi
from
Jackson, TN
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
The Arthritis Clinic
mi
from
Jackson, TN
Click here to add this to my saved trials
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  11/5/2015
mi
from
Knoxville, TN
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Rheumatology Consultants Pllc
mi
from
Knoxville, TN
Click here to add this to my saved trials
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  11/5/2015
mi
from
Memphis, TN
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
The Arthritis Group, Pc
mi
from
Memphis, TN
Click here to add this to my saved trials
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  11/5/2015
mi
from
Nashville, TN
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
St. Thomas Hospital Tower East
mi
from
Nashville, TN
Click here to add this to my saved trials
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  11/5/2015
mi
from
Austin, TX
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Walter F. Chase
mi
from
Austin, TX
Click here to add this to my saved trials
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  11/5/2015
mi
from
Houston, TX
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Rheumatic Disease Clinical Research Center
mi
from
Houston, TX
Click here to add this to my saved trials
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  11/5/2015
mi
from
Houston, TX
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Accurate Clinical Research
mi
from
Houston, TX
Click here to add this to my saved trials
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  11/5/2015
mi
from
Sugarland, TX
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Texas Research Center
mi
from
Sugarland, TX
Click here to add this to my saved trials
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  11/5/2015
mi
from
Arlington, VA
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
The Arthritis Clinic of Northern Virginia, PA
mi
from
Arlington, VA
Click here to add this to my saved trials
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  11/5/2015
mi
from
Chesapeake, VA
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Center for Arthritis and Rheumatic Diseases
mi
from
Chesapeake, VA
Click here to add this to my saved trials
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  11/5/2015
mi
from
Olympia, WA
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
South Puget Sound Clinincal Research Center
mi
from
Olympia, WA
Click here to add this to my saved trials
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  11/5/2015
mi
from
Tacoma, WA
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Tacoma Center for Arthritis Research, PS
mi
from
Tacoma, WA
Click here to add this to my saved trials
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  11/5/2015
mi
from
Ciudad Autonoma,
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Local Institution
mi
from
Ciudad Autonoma,
Click here to add this to my saved trials
Safety and Tolerability of MORAb-022 in Healthy and Rheumatoid Arthritis Subjects
A Randomized, Double-Blind, Placebo-Controlled, Single-Dose, Dose-Escalation Trial of MORAb-022 in Healthy Subjects and Subjects With Rheumatoid Arthritis
Status: Enrolling
Updated:  11/13/2015
mi
from
Los Angeles, CA
Safety and Tolerability of MORAb-022 in Healthy and Rheumatoid Arthritis Subjects
A Randomized, Double-Blind, Placebo-Controlled, Single-Dose, Dose-Escalation Trial of MORAb-022 in Healthy Subjects and Subjects With Rheumatoid Arthritis
Status: Enrolling
Updated: 11/13/2015
Axis Clinical Trials
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Safety and Tolerability of MORAb-022 in Healthy and Rheumatoid Arthritis Subjects
A Randomized, Double-Blind, Placebo-Controlled, Single-Dose, Dose-Escalation Trial of MORAb-022 in Healthy Subjects and Subjects With Rheumatoid Arthritis
Status: Enrolling
Updated:  11/13/2015
mi
from
Jacksonville, FL
Safety and Tolerability of MORAb-022 in Healthy and Rheumatoid Arthritis Subjects
A Randomized, Double-Blind, Placebo-Controlled, Single-Dose, Dose-Escalation Trial of MORAb-022 in Healthy Subjects and Subjects With Rheumatoid Arthritis
Status: Enrolling
Updated: 11/13/2015
Seaview Jacksonville, LLC
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Safety and Tolerability of MORAb-022 in Healthy and Rheumatoid Arthritis Subjects
A Randomized, Double-Blind, Placebo-Controlled, Single-Dose, Dose-Escalation Trial of MORAb-022 in Healthy Subjects and Subjects With Rheumatoid Arthritis
Status: Enrolling
Updated:  11/13/2015
mi
from
Oklahoma City, OK
Safety and Tolerability of MORAb-022 in Healthy and Rheumatoid Arthritis Subjects
A Randomized, Double-Blind, Placebo-Controlled, Single-Dose, Dose-Escalation Trial of MORAb-022 in Healthy Subjects and Subjects With Rheumatoid Arthritis
Status: Enrolling
Updated: 11/13/2015
Lynn Health Science Institute
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Safety and Tolerability of MORAb-022 in Healthy and Rheumatoid Arthritis Subjects
A Randomized, Double-Blind, Placebo-Controlled, Single-Dose, Dose-Escalation Trial of MORAb-022 in Healthy Subjects and Subjects With Rheumatoid Arthritis
Status: Enrolling
Updated:  11/13/2015
mi
from
Duncansville, PA
Safety and Tolerability of MORAb-022 in Healthy and Rheumatoid Arthritis Subjects
A Randomized, Double-Blind, Placebo-Controlled, Single-Dose, Dose-Escalation Trial of MORAb-022 in Healthy Subjects and Subjects With Rheumatoid Arthritis
Status: Enrolling
Updated: 11/13/2015
Altoona Center for Clinical Research
mi
from
Duncansville, PA
Click here to add this to my saved trials
Safety and Tolerability of MORAb-022 in Healthy and Rheumatoid Arthritis Subjects
A Randomized, Double-Blind, Placebo-Controlled, Single-Dose, Dose-Escalation Trial of MORAb-022 in Healthy Subjects and Subjects With Rheumatoid Arthritis
Status: Enrolling
Updated:  11/13/2015
mi
from
Zuidlaren,
Safety and Tolerability of MORAb-022 in Healthy and Rheumatoid Arthritis Subjects
A Randomized, Double-Blind, Placebo-Controlled, Single-Dose, Dose-Escalation Trial of MORAb-022 in Healthy Subjects and Subjects With Rheumatoid Arthritis
Status: Enrolling
Updated: 11/13/2015
Pharmaceutical Research Associates Group B.V.
mi
from
Zuidlaren,
Click here to add this to my saved trials
Assessing the Suitability of an Imaging Probe for Use in Clinical Cell and Gene Therapy Trials in Cancer and Rheumatoid Arthritis
Imaging the Biodistribution of the Positron Emission Tomography Reporter Probe, [18F]FHBG, in Humans.
Status: Enrolling
Updated:  11/16/2015
mi
from
Los Angeles, CA
Assessing the Suitability of an Imaging Probe for Use in Clinical Cell and Gene Therapy Trials in Cancer and Rheumatoid Arthritis
Imaging the Biodistribution of the Positron Emission Tomography Reporter Probe, [18F]FHBG, in Humans.
Status: Enrolling
Updated: 11/16/2015
University of California at Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Assessing the Suitability of an Imaging Probe for Use in Clinical Cell and Gene Therapy Trials in Cancer and Rheumatoid Arthritis
Imaging the Biodistribution of the Positron Emission Tomography Reporter Probe, [18F]FHBG, in Humans.
Status: Enrolling
Updated:  11/16/2015
mi
from
Stanford, CA
Assessing the Suitability of an Imaging Probe for Use in Clinical Cell and Gene Therapy Trials in Cancer and Rheumatoid Arthritis
Imaging the Biodistribution of the Positron Emission Tomography Reporter Probe, [18F]FHBG, in Humans.
Status: Enrolling
Updated: 11/16/2015
Stanford University School of Medicine
mi
from
Stanford, CA
Click here to add this to my saved trials
The CARRA Registry
The CARRA Registry
Status: Enrolling
Updated:  11/16/2015
mi
from
Durham, NC
The CARRA Registry
The CARRA Registry
Status: Enrolling
Updated: 11/16/2015
Duke Clinical Research Institute
mi
from
Durham, NC
Click here to add this to my saved trials
To Evaluate The Effect Of SAR153191 (REGN88) Added To Other RA Drugs In Patients With RA Who Are Not Responding To Or Intolerant Of Anti-TNF Therapy (SARIL-RA-TARGET)
A Randomized, Double-blind, Parallel, Placebo-controlled Study Assessing the Efficacy and Safety of Sarilumab Added to Non-biologic DMARD Therapy in Patients With Rheumatoid Arthritis Who Are Inadequate Responders to or Intolerant of TNF-α Antagonists
Status: Enrolling
Updated:  11/16/2015
mi
from
Anniston, AL
To Evaluate The Effect Of SAR153191 (REGN88) Added To Other RA Drugs In Patients With RA Who Are Not Responding To Or Intolerant Of Anti-TNF Therapy (SARIL-RA-TARGET)
A Randomized, Double-blind, Parallel, Placebo-controlled Study Assessing the Efficacy and Safety of Sarilumab Added to Non-biologic DMARD Therapy in Patients With Rheumatoid Arthritis Who Are Inadequate Responders to or Intolerant of TNF-α Antagonists
Status: Enrolling
Updated: 11/16/2015
Clinical Research Facility
mi
from
Anniston, AL
Click here to add this to my saved trials
To Evaluate The Effect Of SAR153191 (REGN88) Added To Other RA Drugs In Patients With RA Who Are Not Responding To Or Intolerant Of Anti-TNF Therapy (SARIL-RA-TARGET)
A Randomized, Double-blind, Parallel, Placebo-controlled Study Assessing the Efficacy and Safety of Sarilumab Added to Non-biologic DMARD Therapy in Patients With Rheumatoid Arthritis Who Are Inadequate Responders to or Intolerant of TNF-α Antagonists
Status: Enrolling
Updated:  11/16/2015
mi
from
Birmingham, AL
To Evaluate The Effect Of SAR153191 (REGN88) Added To Other RA Drugs In Patients With RA Who Are Not Responding To Or Intolerant Of Anti-TNF Therapy (SARIL-RA-TARGET)
A Randomized, Double-blind, Parallel, Placebo-controlled Study Assessing the Efficacy and Safety of Sarilumab Added to Non-biologic DMARD Therapy in Patients With Rheumatoid Arthritis Who Are Inadequate Responders to or Intolerant of TNF-α Antagonists
Status: Enrolling
Updated: 11/16/2015
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
To Evaluate The Effect Of SAR153191 (REGN88) Added To Other RA Drugs In Patients With RA Who Are Not Responding To Or Intolerant Of Anti-TNF Therapy (SARIL-RA-TARGET)
A Randomized, Double-blind, Parallel, Placebo-controlled Study Assessing the Efficacy and Safety of Sarilumab Added to Non-biologic DMARD Therapy in Patients With Rheumatoid Arthritis Who Are Inadequate Responders to or Intolerant of TNF-α Antagonists
Status: Enrolling
Updated:  11/16/2015
mi
from
Phoenix, AZ
To Evaluate The Effect Of SAR153191 (REGN88) Added To Other RA Drugs In Patients With RA Who Are Not Responding To Or Intolerant Of Anti-TNF Therapy (SARIL-RA-TARGET)
A Randomized, Double-blind, Parallel, Placebo-controlled Study Assessing the Efficacy and Safety of Sarilumab Added to Non-biologic DMARD Therapy in Patients With Rheumatoid Arthritis Who Are Inadequate Responders to or Intolerant of TNF-α Antagonists
Status: Enrolling
Updated: 11/16/2015
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials